Moby Strategic Performance and Operational Drivers. Record Q4 performance was driven by double-digit U.S. Spine growth and ...
Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsBrian Kearns - Senior Vice President of ...
NXT-41x is Elutia's next-generation antibiotic-eluting biomatrix, built on the Company's validated drug-eluting platform. Elutia is applying that platform in plastic and reconstructive surgery, where ...
AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter ...
Globus Medical (NYSE:GMED) reported record Q4 and full year results, supported by its U.S. Spine and Trauma businesses and ...
Globus Medical cites successful integration of NuVasive and Nervo and strong domestic spine sales growth as drivers in strong Q4 results.
The global stem cell therapy market is projected to experience robust growth, with an expected annual growth rate of 20% by 2029. Key drivers behind this expansion include a favorable investment ...
The Spinal Implants Market has emerged as a vital segment within the global medical device industry, driven by the increasing ...
Ursula von der Leyen announced the EU-INC, promising a 48-hour digital incorporation framework to unify Europe’s fragmented market. European Commission President Ursula von der Leyen presented the ...
No two investment firms are exactly alike, which is why we created Inc.'s Founder-Friendly Investors list. These are the private equity, venture capital, and debt specialists that know founders need ...
Wall Street ends higher after Supreme Court rules against Trump tariffs U.S. stocks ended higher on Friday, led by gains in Alphabet, Amazon and other Wall Street heavyweights after the Supreme Court ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results